相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Synthesis of novel thiazolyl hydrazone derivatives as potent dual monoamine oxidase-aromatase inhibitors
Asaf Evrim Evren et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)
Enhancing monoamine oxidase B inhibitory activity via chiral fluorination: Structure-activity relationship, biological evaluation, and molecular docking study
Zhizheng Wang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)
N-Methylpropargylamine-Conjugated Hydroxamic Acids as Dual Inhibitors of Monoamine Oxidase A and Histone Deacetylase for Glioma Treatment
Samir Mehndiratta et al.
JOURNAL OF MEDICINAL CHEMISTRY (2022)
6-Benzyloxyphthalides as selective and reversible monoamine oxidase B inhibitors with antioxidant and anti-neuroinflammatory activities for Parkinson's disease treatment
Qing Song et al.
BIOORGANIC CHEMISTRY (2022)
New Aspects of Monoamine Oxidase B Inhibitors: The Key Role of Halogens to Open the Golden Door
Bijo Mathew et al.
CURRENT MEDICINAL CHEMISTRY (2021)
Discovery of novel and potent safinamide-based derivatives as highly selective hMAO-B inhibitors for treatment of Parkinson's disease (PD): Design, synthesis, in vitro, in vivo and in silico biological studies
Ahmed Elkamhawy et al.
BIOORGANIC CHEMISTRY (2021)
Monoamine oxidases in age-associated diseases: New perspectives for old enzymes
Yohan Santin et al.
AGEING RESEARCH REVIEWS (2021)
New 2-Pyrazoline and Hydrazone Derivatives as Potent and Selective Monoamine Oxidase A Inhibitors
Umut Salgin-Goksen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Monoamine Oxidase Inhibitors: A Review of Their Anti-Inflammatory Therapeutic Potential and Mechanisms of Action
Mahyar Ostadkarampour et al.
FRONTIERS IN PHARMACOLOGY (2021)
A comprehensive review of monoamine oxidase inhibitors as Anti-Alzheimer's disease agents: A review
Shoaib Manzoor et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
A multiple treatment comparison meta-analysis of monoamine oxidase type B inhibitors for Parkinson's disease
C. D. Binde et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2018)
Safinamide in the management of patients with Parkinson's disease not stabilized on levodopa: a review of the current clinical evidence
Sagari Bette et al.
THERAPEUTICS AND CLINICAL RISK MANAGEMENT (2018)
DL-3-n-butylphthalide-Edaravone hybrids as novel dual inhibitors of amyloid-β aggregation and monoamine oxidases with high antioxidant potency for Alzheimer's therapy
Xiaoming Qiang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2017)
Recent developments on the structure-activity relationship studies of MAO inhibitors and their role in different neurological disorders
Bhupinder Kumar et al.
RSC ADVANCES (2016)
Synthesis of a series of unsaturated ketone derivatives as selective and reversible monoamine oxidase inhibitors
Ji Won Choi et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
New Frontiers in Selective Human MAO-B Inhibitors
Simone Carradori et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Evidence that Formulations of the Selective MAO-B Inhibitor, Selegiline, which Bypass First-Pass Metabolism, also Inhibit MAO-A in the Human Brain
Joanna S. Fowler et al.
NEUROPSYCHOPHARMACOLOGY (2015)
Inhibition of monoamine oxidase by phthalide analogues
Belinda Strydom et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
Distribution of monoamine oxidase proteins in human brain: implications for brain imaging studies
Junchao Tong et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2013)
Molecular and Mechanistic Properties of the Membrane-Bound Mitochondrial Monoamine Oxidases
Dale E. Edmondson et al.
BIOCHEMISTRY (2009)
Monoamine oxidase inactivation: From pathophysiology to therapeutics
Marco Bortolato et al.
ADVANCED DRUG DELIVERY REVIEWS (2008)
Oxidative stress and neurotoxicity
Lawrence M. Sayre et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2008)
Structures of human monoamine oxidase B complexes with selective noncovalent inhibitors: Safinamide and coumarin analogs
Claudia Binda et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Solid-phase synthesis and insights into structure-activity relationships of safinamide analogues as potent and selective inhibitors of type B monoamine oxidase
Francesco Leonetti et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Clinical applications of MAO-inhibitors
P Riederer et al.
CURRENT MEDICINAL CHEMISTRY (2004)
Monoamine oxidase expression during development and aging
A Nicotra et al.
NEUROTOXICOLOGY (2004)
Detailed analysis of grid-based molecular docking: A case study of CDOCKER - A CHARMm-based MD docking algorithm
GS Wu et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2003)
Substrate and inhibitor specificities for human monoamine oxidase A and B are influenced by a single amino acid
RM Geha et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
分享论文
